The anticancer activities of wogonin in murine sarcoma S180 both in vitro and in vivo

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 6, 2006, Pages 1132-1137

  Wang, Wei ^a   Guo, Qing Long ^a   You, Qi Dong ^a   Zhang, Kun ^a   Yang, Yong ^a   Yu, Jun ^a   Liu, Wei ^a   Zhao, Li ^a   Gu, Hong Yan ^a   Hu, Yang ^a   Tan, Zi ^b   Wang, Xiao Tang ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Apoptosis; Bax; Bcl 2; Murine sarcoma S180; p53; Wogonin

Indexed keywords

CYCLOPHOSPHAMIDE; DNA FRAGMENT; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; WOGONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER TRANSPLANTATION; CELL LINE; COLORIMETRY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG STRUCTURE; FEMALE; FLUORESCENCE MICROSCOPY; IC 50; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE COUNT; MALE; MICROSCOPY; MOLONEY MURINE SARCOMA ONCOVIRUS; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FEMALE; FLAVANONES; LEUKOCYTE COUNT; LEUKOCYTES; MALE; MICE; MICE, INBRED ICR; MOLECULAR STRUCTURE; NEOPLASM TRANSPLANTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARCOMA 180; SCUTELLARIA BAICALENSIS;

EID: 33744937063     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.1132     Document Type: Article

References (49)

1. Xu S. Y., Bian R. L., Chen X., "Pharmacological Experimental Method," People's Medical Publishing House, Beijing, 1991, p. 1424.
2. Ghobrial I. M., Witzig T. E., Adjei A. A., CA. Cancer J. Clin., 55, 178-194 (2005).
3. Kerr J. F., Winterford C. M., Harmon B. V., Cancer, 73, 2013-2026 (1994).
4. Kerr J. F., Wyllie A. H., Currie A. R., Br. J. Cancer, 26, 239-257 (1972).
5. Wyllie A. H., Kerr J. F., Currie A. R., Int. Rev. Cytol., 68, 251-306 (1980).
6. Earnshaw W. C., Martins L. M., Kaufmann S. H., Annu. Rev. Biochem., 68, 383-424 (1999).
7. Pettersson F., Colston K. W., Dalgleish A. G., Br. J. Cancer, 83, 239-245 (2000).
8. Pettersson F., Colston K. W., Dalgleish A. G., Pancreas, 23, 273-279 (2001).
9. Pan G., O'Rourke K., Chinnaiyan A. M., Gentz R., Ebner R., Ni J., Dixit V. M., Science, 276, 111-113 (1997).
10. Zapata J. M., Pawlowski K., Haas E., Ware C. F., Godzik A., Reed J. C., J. Biol. Chem., 276, 24242-24252 (2001).
11. Zangemeister-Wittke U., Leech S. H., Olie R. A., Simoes-Wust A. P., Gautschi O., Luedke G. H., Natt F., Haner R., Martin P., Hall J., Nalin C. M., Stahel R. A., Clin. Cancer Res., 6, 2547-2555 (2000).
12. Benchimol S., Cell Death Differ., 8, 1049-1051 (2001).
13. Maldonado V., Melendez-Zajgla J., Ortega A., Mutat. Res., 381, 67-75 (1997).
14. Cantley L. C., Science, 296, 1655-1657 (2002).
15. Myung J., Kim K. B., Crews C. M., Med. Res. Rev., 21, 245-273 (2001).
16. Almond J. B., Cohen G. M., Leukemia, 16, 433-443 (2002).
17. Geoerger B., Kerr K., Tang C. B., Fung K. M., Powell B., Sutton L. N., Phillips P. C., Janss A. J., Cancer Res., 61, 1527-1532 (2001).
18. Janus A., Robak T., Smolewski P., Cell. Mol. Biol. Lett., 10, 479-498 (2005).
19. Chi Y. S., Cheon B. S., Kim H. P., Biochem. Pharmacol., 61, 1195-1203 (2001).
20. You K. M., Jong H. G., Kim H. P., Arch. Pharm. Res., 22, 18-24 (1999).
21. Kim H. K., Cheon B. S., Kim Y. H., Kim S. Y., Kim H. P., Biochem. Pharmacol., 58, 759-765 (1999).
22. Wakabayashi I., Yasui K., Eur. J. Pharmacol., 406, 477-481 (2000).
23. Park B. K., Heo M. Y., Park H., Kim H. P., Eur. J. Pharmacol., 425, 153-157 (2001).
24. Gao Z., Huang K., Yang X., Xu H., Biochim. Biophys. Acta, 1472, 643-650 (1999).
25. Shieh D. E., Liu L. T., Lin C. C., Anticancer Res., 20, 2861-2865 (2000).
26. Gao Z., Huang K., Xu H., Pharmacol. Res., 43, 173-178 (2001).
27. Li D. R., Hou H. X., Zhang W., Li L., Ai Zheng, 22, 801-805 (2003).
28. Lee W. R., Shen S. C., Lin H. Y., Hou W. C., Yang L. L., Chen Y. C., Biochem. Pharmacol., 63, 225-236 (2002).
29. Chen Y. C., Shen S. C., Lee W. R., Lin H. Y., Ko C. H., Shih C. M., Yang L. L., Arch. Toxicol., 76, 351-359 (2002).
30. Hui K. M., Huen M. S., Wang H. Y., Zheng H., Sigel E., Baur R., Ren H., Li Z. W., Wong J. T., Xue H., Biochem. Pharmacol., 64, 1415-1424 (2002).
31. Zheng H. Z., Dong Z. H., She J., "Modern Study of Traditional Chinese Medicine," Vol. 4, Xue Yuan Press, Beijing, 1998, p. 3943.
32. Hao L. L., Mei Q. B., Zhang B. L., Jia M., Li X. Q., Zhang F., Acta Pharmacol. Sin., 25, 1509-1514 (2004).
33. Burlacu A., J. Cell. Mol. Med., 7, 249-257 (2003).
34. Afford S., Randhawa S., Mol. Pathol., 53, 55-63 (2000).
35. Tamm I., Schriever F., Dorken B., Lancet Oncol., 2, 33-42 (2001).
36. Pattingre S., Tassa A., Qu X., Garuti R., Liang X. H., Mizushima N., Packer M., Schneider M. D., Levine B., Cell, 122, 927-939 (2005).
37. Kawai-Yamada M., Saito Y., Jin L., Ogawa T., Kim K. M., Yu L. H., Tone Y., Hirata A., Umeda M., Uchimiya H., J. Biol. Chem., 280, 39468-39473 (2005).
38. Reed J. C., Semin. Hematol., 34, 9-19 (1997).
39. Pettersson F., Dalgleish A. G., Bissonnette R. P., Colston K. W., Br. J. Cancer, 87, 555-561 (2002).
40. Heimlich G., McKinnon A. D., Bernardo K., Brdiczka D., Reed J. C., Kain R., Kronke M., Jurgensmeier J. M., Biochem. J., 378, 247-255 (2004).
41. Sato T., Hanada M., Bodrug S., Irie S., Iwama N., Boise L. H., Thompson C. B., Golemis E., Fong L., Wang H. G., Reed J. C. Proc. Natl. Acad. Sci. U.S.A., 91, 9238-9242 (1994).
42. Timothy M. C., John S., "Molecular Biology in Medicine," Science Press, Peking, 2003, pp. 167-168.
43. el-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Vogelstein B., Cell, 75, 817-825 (1993).
44. Hartwell L. H., Kastan M. B., Science, 266, 1821-1828 (1994).
45. Hsia J. Y., Chen C. Y., Hsu C. P., Shai S. E., Yang S. S., Chuang C. Y., Wang P. Y., Chen J. T., Neoplasma, 48, 483-488 (2001).
46. Streffer J. R., Rimner A., Rieger J., Naumann U., Rodemann H. P., Weller M., J. Neurooncol., 56, 43-49 (2002).
47. Bandoh N., Hayashi T., Kishibe K., Takahara M., Imada M., Nonaka S., Harabuchi Y., Cancer, 94, 1968-1980 (2002).
48. Communal C., Sumandea M., de Tombe P., Narula J., Solaro R. J., Hajjar R. J., Proc. Natl. Acad. Sci. U.S.A., 99, 6252-6256 (2002).
49. Gao C. F., Ren S., Zhang L., Nakajima T., Ichinose S., Hara T., Koike K., Tsuchida N., Exp. Cell Res., 265, 145-151 (2001).